Annual report
7090.TEDINET S100OFW0
Period2021-04-01 → 2022-03-31
Filed2022-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 149
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥2.7bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥2.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.5bn | 2017-04-01 → 2018-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥159m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥247m | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥151m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥240m | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥204m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥65m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥162m | 2017-04-01 → 2018-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥119m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥237m | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥72m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥157m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥143m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥36m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥74m | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥72m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥157m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥3.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥3.3bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥908m | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥705m | at 2018-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.1bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.3bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥822m | at 2020-03-31d | Cons. | Net assets |
| Net assets / equity | ¥160m | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥155m | at 2018-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥932m | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥282m | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥194m | at 2018-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥80m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥207m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥367m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥141m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥475m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥496m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥226m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥52m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥108m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥154m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.3bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥509m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥137m | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥36m | 2017-04-01 → 2018-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥51.64 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.5 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥138.96 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.18 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.85 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥50.55 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥110.43 | 2020-04-01 → 2021-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥129.49 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥811.24 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥761.05 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥631.64 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥157.92 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥153.41 | at 2018-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 34.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.9% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.1% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.6% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.0% | at 2018-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 6.6% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.7% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 29.1% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 22.6% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 62.3% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 156 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 121 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 85 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 82 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 62 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥1.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥1.5bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.2bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥36m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥127m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥30m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥118m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥162m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥41m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥152m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥17m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥114m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥6m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥72m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥112m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥17m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥64m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.8bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥2.9bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥1.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥783m | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥668m | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.8bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.9bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥979m | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥959m | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥808m | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥176m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥160m | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥864m | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥4.01 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.3 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.01 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.31 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.36 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥3.92 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥50.52 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥101.58 | 2019-04-01 → 2020-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥693.47 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥689.6 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥620.81 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥174.39 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥158.08 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.0% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.7% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.5% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 23.9% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 0.6% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.7% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.8% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 50.1% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,415,800 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,391,100 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,301,500 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,011,900 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,011,900 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 77 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 61 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 57 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 55 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 40 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Financial Services Segmentsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥6m |
| Financial Services Segmentsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| Financial Services Segmentsreportable segment | employees | at 2022-03-31 | 35 pure |
| Financial Services Segmentsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥877m |
| Financial Services Segmentsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥877m |
| Financial Services Segmentsreportable segment | segment assets | at 2022-03-31 | ¥214m |
| Financial Services Segmentsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥24m |
| Osteopathic Solution Segmentsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥303m |
| Osteopathic Solution Segmentsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥190m |
| Osteopathic Solution Segmentsreportable segment | employees | at 2022-03-31 | 121 pure |
| Osteopathic Solution Segmentsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Osteopathic Solution Segmentsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.3bn |
| Osteopathic Solution Segmentsreportable segment | segment assets | at 2022-03-31 | ¥3.1bn |
| Osteopathic Solution Segmentsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥134m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥308m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥192m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| —segment total | segment assets | at 2022-03-31 | ¥3.3bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥159m |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥208,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥208,000 |
| Financial Services Segmentsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥6m |
| Financial Services Segmentsreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥2m |
| Financial Services Segmentsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥877m |
| Financial Services Segmentsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥877m |
| Financial Services Segmentsreportable segment | segment assets | at 2021-03-31 | ¥272m |
| Financial Services Segmentsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥50m |
| Osteopathic Solution Segmentsreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥490m |
| Osteopathic Solution Segmentsreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥79m |
| Osteopathic Solution Segmentsreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥1.8bn |
| Osteopathic Solution Segmentsreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥1.8bn |
| Osteopathic Solution Segmentsreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥208,000 |
| Osteopathic Solution Segmentsreportable segment | segment assets | at 2021-03-31 | ¥3.0bn |
| Osteopathic Solution Segmentsreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥197m |
| —segment total | capex | 2020-04-01 → 2021-03-31 | ¥496m |
| —segment total | depreciation | 2020-04-01 → 2021-03-31 | ¥80m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥2.7bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥2.7bn |
| —segment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥208,000 |
| —segment total | segment assets | at 2021-03-31 | ¥3.3bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥247m |
| Osteopathic Solution Segmentsreportable segment | employees | at 2022-03-31 | 77 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,218
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | CurrentYearDuration | 3202949000 | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration | － | JPY |
| Net sales | CurrentYearDuration_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 2325744000 | JPY |
| Net sales | CurrentYearDuration_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | 877205000 | JPY |
| Net sales | CurrentYearDuration_ReportableSegmentsMember | 3202949000 | JPY |
| Net sales | CurrentYearDuration | 3202949000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 134148000 | JPY |
| Operating income | CurrentYearDuration_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | 24352000 | JPY |
| Operating income | CurrentYearDuration_ReportableSegmentsMember | 158501000 | JPY |
| Operating income | CurrentYearDuration | 158501000 | JPY |
| Assets | CurrentYearInstant_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 3065783000 | JPY |
| Assets | CurrentYearInstant_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | 213933000 | JPY |
| Assets | CurrentYearInstant_ReportableSegmentsMember | 3279717000 | JPY |
| Assets | CurrentYearInstant | 3279717000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 190256000 | JPY |
| Depreciation segment information | CurrentYearDuration_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | 2016000 | JPY |
| Depreciation segment information | CurrentYearDuration_ReportableSegmentsMember | 192272000 | JPY |
| Depreciation segment information | CurrentYearDuration | 192272000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 8695000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | － | JPY |
| Amortization of goodwill sga | CurrentYearDuration_ReportableSegmentsMember | 8695000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration | 8695000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 302637000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | 5616000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration_ReportableSegmentsMember | 308254000 | JPY |
| Increase in property plant and equipment and intangible assets | CurrentYearDuration | 308254000 | JPY |
| Amortization of goodwill sga | Prior1YearDuration_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 5940000 | JPY |
| Amortization of goodwill sga | Prior1YearDuration_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | － | JPY |
| Amortization of goodwill sga | Prior1YearDuration | 5940000 | JPY |
| Goodwill | Prior1YearInstant_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 36342000 | JPY |
| Goodwill | Prior1YearInstant_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | － | JPY |
| Goodwill | Prior1YearInstant | 36342000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 8695000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | － | JPY |
| Amortization of goodwill sga | CurrentYearDuration | 8695000 | JPY |
| Goodwill | CurrentYearInstant_jpcrp030000-asr_E33790-000OsteopathicSolutionSegmentsReportableSegmentsMember | 165945000 | JPY |
| Goodwill | CurrentYearInstant_jpcrp030000-asr_E33790-000FinancialServicesSegmentsReportableSegmentsMember | － | JPY |
| Goodwill | CurrentYearInstant | 165945000 | JPY |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 1559866000 | JPY |
| Cash and deposits | CurrentYearInstant_NonConsolidatedMember | 863631000 | JPY |
| Accounts receivable trade | Prior1YearInstant_NonConsolidatedMember | 190193000 | JPY |
| Accounts receivable trade | CurrentYearInstant_NonConsolidatedMember | 204742000 | JPY |
| Merchandise | Prior1YearInstant_NonConsolidatedMember | 73439000 | JPY |
| Merchandise | CurrentYearInstant_NonConsolidatedMember | 187107000 | JPY |
| Supplies | Prior1YearInstant_NonConsolidatedMember | － | JPY |
| Supplies | CurrentYearInstant_NonConsolidatedMember | 25835000 | JPY |
| Advance payments trade | Prior1YearInstant_NonConsolidatedMember | 16543000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |